EP0316408A1 - Procede d'inhibition de tumeurs chez les animaux a sang chaud - Google Patents

Procede d'inhibition de tumeurs chez les animaux a sang chaud

Info

Publication number
EP0316408A1
EP0316408A1 EP88904876A EP88904876A EP0316408A1 EP 0316408 A1 EP0316408 A1 EP 0316408A1 EP 88904876 A EP88904876 A EP 88904876A EP 88904876 A EP88904876 A EP 88904876A EP 0316408 A1 EP0316408 A1 EP 0316408A1
Authority
EP
European Patent Office
Prior art keywords
ghl
glycyl
tumor
tumors
copper
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP88904876A
Other languages
German (de)
English (en)
Inventor
Loren Ralph Pickart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procyte Corp
Original Assignee
Procyte Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procyte Corp filed Critical Procyte Corp
Publication of EP0316408A1 publication Critical patent/EP0316408A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Sont décrits des procédés permettant d'inhiber la croissance de tumeurs chez les animaux à sang chaud. Les procédés emploient des quantités efficaces de compositions comprenant GHL-Cu (Glycidile-histidyle-lysine-Cu) ou un dérivé de celui-ci. Les compositions peuvent également comprendre de l'acide ascorbique.
EP88904876A 1987-05-11 1988-05-11 Procede d'inhibition de tumeurs chez les animaux a sang chaud Withdrawn EP0316408A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4844387A 1987-05-11 1987-05-11
US48443 1998-03-26

Publications (1)

Publication Number Publication Date
EP0316408A1 true EP0316408A1 (fr) 1989-05-24

Family

ID=21954614

Family Applications (1)

Application Number Title Priority Date Filing Date
EP88904876A Withdrawn EP0316408A1 (fr) 1987-05-11 1988-05-11 Procede d'inhibition de tumeurs chez les animaux a sang chaud

Country Status (5)

Country Link
EP (1) EP0316408A1 (fr)
JP (1) JPH02500368A (fr)
KR (1) KR890701115A (fr)
AU (1) AU1799588A (fr)
WO (1) WO1988008715A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7665979B2 (en) 2002-08-02 2010-02-23 Eos Gmbh Electro Optical Systems Device and method for the production of three-dimensional objects by means of generative production method

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4937230A (en) * 1985-01-24 1990-06-26 Procyte Corporation Method of healing wounds in horses
US4767753A (en) * 1985-02-08 1988-08-30 Procyte Corporation Methods and compositions for preventing ulcers
WO1989005659A1 (fr) * 1987-12-24 1989-06-29 Borody Thomas J Solutions de lavage orthostatique
US5118665A (en) * 1990-02-09 1992-06-02 Procyte Corporation Anti-oxidative and anti-inflammatory metal:peptide complexes and uses thereof
US5164367A (en) * 1990-03-26 1992-11-17 Procyte Corporation Method of using copper(ii) containing compounds to accelerate wound healing
AU776732B2 (en) * 1999-10-04 2004-09-23 John Carter Pharmaceutical compositions containing copper, salicylic acid and vitamines C
EP1680073B1 (fr) 2003-10-21 2013-01-02 IGF Oncology, LLC Composes et methode de traitement du cancer
US9011880B2 (en) 2003-10-21 2015-04-21 Igf Oncology, Llc Compounds and methods for treating cancer
WO2005072292A2 (fr) * 2004-01-24 2005-08-11 Hugh Mctavish Procedes d'amelioration de radiotherapie
CA2582552A1 (fr) 2004-10-21 2006-05-04 Igf Oncology, Llc Toxines et radionucleides couples aux ligands du recepteur igf-1 pour le traitement d'un cancer
CA2936675C (fr) 2014-01-12 2023-06-27 Igf Oncology, Llc Proteines de fusion contenant un facteur-1 de croissance de type insuline et un facteur de croissance epidermique et leurs variantes, et leurs utilisations
WO2018217669A1 (fr) 2017-05-21 2018-11-29 Igf Oncology, Llc Conjugué de facteur de croissance insuline-like - produit chimiothérapeutique pour le traitement du syndrome myélodysplasique

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2827478A1 (de) * 1978-06-22 1980-01-17 Jozsef Dr Beres Arzneimittel, insbesondere zur heilung von und vorbeugung gegen geschwulstkrankheiten
DE3440090A1 (de) * 1984-11-02 1986-05-07 Novo-Med AG, Appenzell Aminosaeureloesungen enthaltendes arzneimittel zur therapie von krebserkrankungen und verfahren zu seiner herstellung
WO1987003481A1 (fr) * 1985-12-05 1987-06-18 American Biotechnology Co., Ltd. Agents anti-tumoraux du type anthracycline avec de l'acide l-ascorbique

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO8808715A1 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7665979B2 (en) 2002-08-02 2010-02-23 Eos Gmbh Electro Optical Systems Device and method for the production of three-dimensional objects by means of generative production method

Also Published As

Publication number Publication date
KR890701115A (ko) 1989-12-19
JPH02500368A (ja) 1990-02-08
WO1988008715A1 (fr) 1988-11-17
AU1799588A (en) 1988-12-06

Similar Documents

Publication Publication Date Title
EP0313643B1 (fr) Procedes et compositions destines a prevenir les ulceres
AU648517B2 (en) Methods and compositions for healing ulcers
US5164367A (en) Method of using copper(ii) containing compounds to accelerate wound healing
US5118665A (en) Anti-oxidative and anti-inflammatory metal:peptide complexes and uses thereof
US5145838A (en) Methods and compositions for healing ulcers
JP3174323B2 (ja) 毛髪成長を刺激するための金属―ペプチド組成物及び方法
EP0314755B1 (fr) Utilisation de dérivés de GHL-Cu pour la préparation d'un médicament pour stimuler la croissance pilaire
US4877770A (en) Chemical derivatives of GHL-Cu
CA2081308A1 (fr) Methode permettant d'augmenter la permeabilite de la barriere hemato-encephallique
EP0190736A2 (fr) Dérivés chimiques du GHL-Cu
EP0316408A1 (fr) Procede d'inhibition de tumeurs chez les animaux a sang chaud
US5736519A (en) Peptide, a method for its preparation and a pharmaceutical composition containing the peptide
US4256632A (en) Novel derivatives of daunomycin
CA1239393A (fr) Compositions inhibitrices de collagene, leur fabrication et leur emploi
RU2362579C1 (ru) Фармацевтическая композиция на основе пептида, обладающего противоопухолевым действием
GB2213060A (en) Healing wounds in horses
US5114926A (en) Tetrapeptide inhibiting the entry into cycle of hemopoietic stem cells processes for its preparation, and its uses
EP0288278B1 (fr) Dérivés chimiques du GHL-Cu
JPH0232095A (ja) 免疫機構の機能を仰制する新規ペプチド、それらを含む医薬組成物、並びに前記ペプチド及び医薬組成物の調製方法
US6103699A (en) Peptide, a method for its preparation and a pharmaceutical composition containing the peptide
JPH0796557B2 (ja) 新規ペプチド、その製法およびそれを含有する医薬組成物
JPH0971528A (ja) 抗腫瘍剤
DE3873255T2 (de) Methoden und praeparate zur vorbeugung von ulcera.
JPH07506564A (ja) 医薬的ペンタペプチド組成物およびその使用法

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

17P Request for examination filed

Effective date: 19890410

17Q First examination report despatched

Effective date: 19900411

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19901023